Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections-Reference-Cited by-同舟云学术

Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections

Published:2018-04 Issue:6 Volume:78 Page:675-692
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Shirley Matt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-018-0902-x/fulltext.html

Reference65 articles.

1. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1 . Accessed 16 Mar 2018.

2. Tängdén T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med. 2015;277(5):501–12.

3. Zowawi HM, Harris PNA, Roberts MJ, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12(10):570–84.

4. Bush K. Bench-to-bedside review: the role of β-lactamases in antibiotic-resistant Gram-negative infections. Crit Care. 2010;14(3):224.

5. Pitout JDD. Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010;70(3):313–33.

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime-avibactam versus other antimicrobial agents for treatment of Multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis;Infection;2024-08-24

2. Antibiotic Susceptibility of Aerobic and Facultative Anaerobic Gram-Negative Rods in Hong Kong and Implications on Usefulness of Ceftazidime-Avibactam and Ceftolozane-Tazobactam;Antibiotics;2024-08-24

3. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review;Pharmaceuticals;2024-08-23

4. Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis;International Journal of Antimicrobial Agents;2024-08

5. Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice;The Journal of Infection in Developing Countries;2024-07-29